Resistance to Targeted Therapies in Breast Cancer

de

Éditeur :

Springer


Collection :

Resistance to Targeted Anti-Cancer Therapeutics

Paru le : 2017-12-04

eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
105,49

Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.
Pages
184 pages
Collection
Resistance to Targeted Anti-Cancer Therapeutics
Parution
2017-12-04
Marque
Springer
EAN papier
9783319701417
EAN PDF
9783319701424

Informations sur l'ebook
Nombre pages copiables
1
Nombre pages imprimables
18
Taille du fichier
3543 Ko
Prix
105,49 €